Share Email Print

Proceedings Paper

(Re)defining sensitivity of chemical imaging
Author(s): Sean P. O'Connor; Joshua Lalonde; Dawson T. Nodurft; Vladislav V. Yakovlev
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

To successfully develop and manufacture a generic drug product, the latter is expected to be bioequivalent to its referencelisted drug, i.e. to show no significant difference in the rate and extent of absorption of the active pharmaceutical ingredient. Optical spectroscopy methods based on vibrational spectroscopy imaging have recently attracted significant attention as potentially viable approaches to quantify drugs’ pharmacokinetics in vivo. However, substantial hurdles still exist due to signal interference from surrounding tissues, significant attenuation of signal in the depth of tissue to optical absorption and scattering, and a lack of quantifiable ways of assessing the signal generated from a drug compound in the depth of a tissue. In this report, we evaluated the major challenges of quantification and sensitive and reproducible analysis of drug distribution in tissues using Raman spectroscopy. Specific attention is given to the noise assessment, which affects both the sensitivity and reproducibility of data.

Paper Details

Date Published: 4 March 2019
PDF: 6 pages
Proc. SPIE 10859, Visualizing and Quantifying Drug Distribution in Tissue III, 108590H (4 March 2019); doi: 10.1117/12.2510974
Show Author Affiliations
Sean P. O'Connor, Texas A&M Univ. (United States)
Joshua Lalonde, Texas A&M Univ. (United States)
Dawson T. Nodurft, Texas A&M Univ. (United States)
Vladislav V. Yakovlev, Texas A&M Univ. (United States)

Published in SPIE Proceedings Vol. 10859:
Visualizing and Quantifying Drug Distribution in Tissue III
Kin Foong Chan; Conor L. Evans, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?